Loading...
XNAS
BCPC
Market cap4.87bUSD
Dec 05, Last price  
150.50USD
1D
-1.86%
1Q
-6.61%
Jan 2017
79.34%
Name

Balchem Corp

Chart & Performance

D1W1MN
XNAS:BCPC chart
P/E
37.94
P/S
5.11
EPS
3.97
Div Yield, %
Shrs. gr., 5y
0.13%
Rev. gr., 5y
8.18%
Revenues
954m
+3.39%
839,095,000100,905,000176,201,000232,050,000219,438,000255,071,000291,867,000310,393,000337,173,000541,383,000552,492,000553,204,000594,790,000643,679,000643,705,000703,644,000799,023,000942,358,000922,439,000953,684,000
Net income
128m
+18.36%
10,954,00012,278,00016,118,00019,050,00026,785,00033,277,00038,765,00040,005,00044,874,00052,826,00059,722,00055,972,00090,071,00078,573,00079,671,00084,623,00096,104,000105,367,000108,543,000128,475,000
CFO
182m
-0.96%
13,698,00016,370,00015,637,00022,897,00048,072,00039,030,00044,902,00053,781,00055,692,00085,350,000103,826,000107,612,000110,618,000118,697,000124,461,000150,494,000160,514,000138,536,000183,761,000181,999,000
Dividend
Dec 26, 20230.79 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
IPO date
Jun 03, 1986
Employees
1,284
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT